Zacks Research Weighs in on Chemours' Q2 Earnings (NYSE:CC)

The Chemours Company (NYSE:CC - Free Report) - Equities research analysts at Zacks Research decreased their Q2 2025 EPS estimates for Chemours in a research note issued on Monday, March 3rd. Zacks Research analyst R. Department now anticipates that the specialty chemicals company will earn $0.58 per share for the quarter, down from their prior forecast of $0.71. The consensus estimate for Chemours' current full-year earnings is $2.03 per share. Zacks Research also issued estimates for Chemours' Q3 2025 earnings at $0.54 EPS, Q2 2026 earnings at $0.69 EPS, FY2026 earnings at $2.39 EPS and FY2027 earnings at $2.67 EPS.

Chemours (NYSE:CC - Get Free Report) last posted its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The company had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.37 billion.

Several other brokerages have also commented on CC. BMO Capital Markets dropped their price target on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 19th. The Goldman Sachs Group dropped their price target on shares of Chemours from $24.00 to $21.00 and set a "neutral" rating on the stock in a research note on Tuesday, January 7th. Barclays dropped their price target on shares of Chemours from $23.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Monday, February 24th. Truist Financial initiated coverage on shares of Chemours in a research note on Tuesday, January 28th. They issued a "buy" rating and a $27.00 price target on the stock. Finally, Morgan Stanley dropped their price target on shares of Chemours from $25.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Monday, January 13th. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, Chemours currently has a consensus rating of "Hold" and a consensus price target of $23.11.

Remove Ads

Chemours Stock Up 0.8 %

Shares of CC stock traded up $0.12 during trading hours on Wednesday, reaching $14.11. 3,951,679 shares of the stock were exchanged, compared to its average volume of 1,533,621. The business's fifty day moving average is $17.51 and its two-hundred day moving average is $18.67. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92. Chemours has a 12-month low of $13.31 and a 12-month high of $29.21. The firm has a market capitalization of $2.11 billion, a P/E ratio of 24.75 and a beta of 2.00.

Institutional Investors Weigh In On Chemours

Hedge funds and other institutional investors have recently bought and sold shares of the business. GAMMA Investing LLC lifted its holdings in Chemours by 99.7% in the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock valued at $26,000 after acquiring an additional 765 shares during the period. Truvestments Capital LLC acquired a new stake in Chemours in the third quarter valued at $35,000. Brooklyn Investment Group acquired a new position in shares of Chemours during the 3rd quarter worth $37,000. Quadrant Capital Group LLC raised its stake in shares of Chemours by 100.4% during the 4th quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company's stock worth $38,000 after buying an additional 1,119 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd acquired a new position in shares of Chemours during the 4th quarter worth $48,000. Institutional investors and hedge funds own 76.26% of the company's stock.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 7.09%. The ex-dividend date is Friday, February 28th. Chemours's dividend payout ratio is presently 175.44%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.